Histiocytosis disorders in Northeast Egypt: epidemiology and survival studies (a 5-year study)

References

• Ornvold K, Carstensen H, Larsen JK. Flow cytometric DNA analysis of lesions from 18 children with langerhans cell histiocytosis (histiocytosis x). Am J Pathol 1990; 136: 1301–1307.
   PubMed Web of Science ®Google Scholar
• Bhatia S, Nesbit ME Jr, Egeler RM. Epidemiologic study of Langerhans cell histiocytosis in children. Pediatr 1997; 130: 774–784.
   Web of Science ®Google Scholar
• Greenberger JS, Cassady JR, Jaffe R. Radiation therapy in patients with histiocytosis: management of diabetes insipidus and bone lesions. Int J Radiat Oncol Biol Phys 1979; 5: 1749–1755.
   PubMed Web of Science ®Google Scholar
• Braunstein GD, Kohler PO. Endocrine manifestations of histiocy-tosis. Am J Pediatr Hematol Oncol 1981; 3: 67–75.
   PubMedGoogle Scholar
• Rosenzweig KE, Arceci RJ, Tarbell Ni. Diabetes insipidus secondary to Langerhans' cell histiocytosis: is radiation therapy indicated? Med Pediatr Oncol 1997; 29: 36–40.
   PubMedGoogle Scholar
• Lookingbill DP. Histiocytosis X confined to the skin of the scalp.J Am Acad Dermatol 1984; 10: 968–969.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Kagetsu N, Taniguchi Y. Immunohistochemistry and electron microscopy in Langerhans cell histiocytosis confined to the skin. J Am Acad Dermatol 1991; 25: 1044–1053.
   PubMed Web of Science ®Google Scholar
• Johno M, Oishi M, Kohmaru M. Langerhans cell histiocytosis presenting as a varicelliform eruption over the entire skin. J Dermatol 1994; 21: 197–204.
   PubMedGoogle Scholar
• Munn S, Chu AC. Langerhans cell histiocytosis of the skin. Hematol Oncol Clin North Am 1998; 12: 269–286.
   PubMed Web of Science ®Google Scholar
• Ha SY, Helms P, Fletcher M. Lung involvement in Langerhans' cell histiocytosis: prevalence, clinical features, and outcome. Pediatrics 1992; 89: 466–469.
   PubMed Web of Science ®Google Scholar
• Vassalo R, Ryu JH, Colby TV. Pulmonary Langerhans cell histiocytosis. N Engl J Med 2000; 342: 1969–1978.
   PubMed Web of Science ®Google Scholar
• Motoi M, Helbron D, Kaiserling E, Lennert K. Eosinophilic granuloma of lymph nodes, a variant of histiocytosis X. Histopathology 1980; 4: 585–606.
   PubMed Web of Science ®Google Scholar
• Sacks SH, Hall I, Ragge N, Pritchard J. Chronic dermal sinuses as a manifestation of histiocytosis X. Br Med J 1986, 292, 1097-1098.
   PubMed Web of Science ®Google Scholar
• Rosenfield NS, Abrahams J, Komp D. Brain MR in patients with Langerhans cell histiocytosis: findings and enhancement with Gd-DTPA. Pediatr Radiol 1990; 20: 433–436.
   PubMed Web of Science ®Google Scholar
• Kaltsas GA, Powles TB, Evanson J. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 2000; 85: 1370–1376.
   PubMed Web of Science ®Google Scholar
• Lampert F. Langerhans cell histiocytosis. Historical perspectives. Hematol Oncol Clin North Am 1998; 12: 213–219.
   PubMed Web of Science ®Google Scholar
• Katz SI, Tamaki K, Sachs DH. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 1979; 282: 324–326.
   PubMed Web of Science ®Google Scholar
• Gonzalez CL, Jaffe ES. The histiocytoses: clinical presentation and differential diagnosis. Oncology (Huntingt) 1990; 4: 47–62.
   PubMedGoogle Scholar
• Steinman RM, Pack M, Inaha K. Dendritic cell development and maturation in dendritic cells. In: Ricciardi-Castagnol (ed) Fundamental and clinical immunology. New York, NY: Plenum Press, 1997; 1–5.
   Google Scholar
• Caux C, Liu YJ, Banchereau J. Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol Today 1995; 16: 2–4.
   PubMedGoogle Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245–252.
   PubMed Web of Science ®Google Scholar
• Kiertscher SM, Luo J, Dubinett SM. Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J Immunol 2000; 164: 1269–1276.
   PubMed Web of Science ®Google Scholar
• Pirtskhalaishvili G, Shurin GV, Gambotto A. Transduction of dendritic cells with Bc1-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice. J Immunol 2000; 165: 1956–1964.
   PubMed Web of Science ®Google Scholar
• Leahy MA, Krejci SM, Friednash M. Human herpesvirus 6 is present in lesions of Langerhans cell histiocytosis. J Invest Dermatol 1993; 101: 642–645.
   PubMed Web of Science ®Google Scholar
• Hage C, Willman CL, Favara BE, Isaacson PG. Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction. Hum Pathol 1993; 24: 840–845.
   PubMed Web of Science ®Google Scholar
• Willman CL, Busque L, Griffith BB. Langerhans'-cell histiocytosis (histiocytosis X)-a clonal proliferative disease. N Engl J Med 1994; 331: 154–160.
   PubMed Web of Science ®Google Scholar
• Yu RC, Chu C, Buluwela L, Chu AC. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet 1994; 343: 767–768.
   PubMed Web of Science ®Google Scholar
• Kannourakis G, Abbas A. The role of cytokines in the pathogen-esis of Langerhans cell histiocytosis. Br J Cancer 1994; 23: 37–40.
   Google Scholar
• Egeler RM, Favara BE, van Meurs M. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 1999; 94: 4195–4201.
   PubMed Web of Science ®Google Scholar
• Katz AM, Rosenthal D, Jakubovic HR. Langerhans cell histiocy-tosis in monozygotic twins. J Am Acad Dermatol 1991; 24: 32–37.
   PubMed Web of Science ®Google Scholar
• Yu RC, Chu AC. Lack of T-cell receptor gene rearrangements in cells involved in Langerhans cell histiocytosis. Cancer 1995; 75: 1162–1166.
   PubMed Web of Science ®Google Scholar
• Ruco LP, Stoppacciaro A, Vitolo D. Expression of adhesion molecules in Langerhans' cell histiocytosis. Histopathology 1993; 23: 29–37.
   PubMed Web of Science ®Google Scholar
• de Graaf JH, Tamminga RY, Kamps WA, Timens W. Langerhans' cell histiocytosis: expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation. Am J Pathol 1994; 144: 466–472.
   PubMed Web of Science ®Google Scholar
• de Graaf JH, Tamminga RY, Kamps WA, Timens W. Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells. Am J Pathol 1995; 147: 1161–1171.
   PubMed Web of Science ®Google Scholar
• McClain K, Jin H, Gresik V. Langerhans cell histiocytosis: lack of a viral etiology. Am J Hematol 1994; 47: 16–20.
   PubMed Web of Science ®Google Scholar
• Mierau GW, Wills EJ, Steele PO. Ultrastructural studies in Langerhans cell histiocytosis: a search for evidence of viral etiology. Pediatr Pathol 1994; 14: 895–904.
   PubMed Web of Science ®Google Scholar
• Egeler RM. Genetic predisposition in Langerhans cell histiocyto-sis? A hypothesis. Langerhans cell histiocytosis and other histiocytic disorders. Thesis, University of Amsterdam, Haveka BV Alblasserdam, the Netherlands; 1993,181–197.
   Google Scholar
• Hoeger PH, Nanduri VR, Harper J. Long term follow up of topicalmustine treatment for cutaneous langerhans cell histiocytosis. Arch Dis Child 2000; 82: 483–487.
   PubMed Web of Science ®Google Scholar
• Arceci RJ. The histiocytosis: the fall of the Tower of Babel. Eur J Cancer 1999; 35: 747–769.
   PubMed Web of Science ®Google Scholar
• Gadner H, Heitger A, Grois N. Treatment strategy for dissemi-nated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol 1994; 23: 72–80.
   PubMedGoogle Scholar
• Harris NL, Jaffe R, Diebold J. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849.
   PubMed Web of Science ®Google Scholar
• Arceci RJ, Brenner MK, Pritchard J. Controversies and new approaches to treatment of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998; 12: 339–357.
   PubMed Web of Science ®Google Scholar
• Favara BE, Jaffe R, Egeler M. Macrophage activation and hemophagocytic syndrome in Langerhans cell histiocytosis: report of 30 cases. Pediatr Dev Pathol 2002; 5: 130–140.
   PubMed Web of Science ®Google Scholar
• AL-Molhim I, Sabbah RS, EL-Akkad SM. Langerhan's cell histiocytosis in Saudi Arabia. Indian J Cancer 1991; 28: 53–60.
   PubMedGoogle Scholar
• Miiller J, Koos R, Garami M, Hauser P, Borgulya G. Experiences with Langerhans' cell histiocytosis in children in Hungary. Magy Onkol 2004; 48: 289–295.
   PubMedGoogle Scholar
• Braier J, Chantada G, Rosso D, Bernaldez P. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution. Pediatr Hematol Oncol 1999; 16: 377–385.
   PubMed Web of Science ®Google Scholar
• Jubran RF, Marachelian A, Dorey F, Malogolowskin M. Predictors of outcome in children with Langerhans cell histiocy-tosis. Pediatr Blood Cancer 2005; 45(1): 37–42.
   PubMed Web of Science ®Google Scholar
• Stiakaki E, Giannakopoulou C, Kouvidi E. Congenital systemic Langerhans cell histiocytosis (report of two cases). Haematologia 1997; 28: 215–222.
   PubMedGoogle Scholar
• Chu T, D'Angio GJ, Favara BE, Ladisch S, Nesbit M, Pritchard J. Histiocytosis syndromes in children. Lancet 1987; 2: 1091–1092.
   Web of Science ®Google Scholar
• Chen RL, Lin KS, Chang WH, Hsieh YL. Childhood Langerhans cell histiocytosis increased during El Nino 1997-98: a report from the Taiwan Pediatric Oncology Group. Acta Paediatr Taiwan 2003; 44: 14–20.
   PubMedGoogle Scholar
• Ceci A, de Terlizzi M, Toma MG. Heterogeneity of immunologicalpatterns in Langerhans cell histiocytosis and response to crude calf thymic extract in 11 patients. Med Pediatr Oncol 1988; 16: 111–115.
   PubMedGoogle Scholar
• Chhabra UD, Desai SS, Jambhekar NA. Langerhans' cell histiocytosis: a clinicopathological study of 50 cases. Indian J Pathol Microbiol 2004; 47: 370–376.
   PubMedGoogle Scholar